Moderna’s mRNA RSV Vaccine Shows Positive Results in Phase 3 Trial
January 3rd 2024The vaccine, called mRNA-1345, demonstrated an efficacy of 83.7% against RSV-associated lower respiratory tract disease with at least 2 signs or symptoms and 82.4% against the disease with at least 3 signs or symptoms.
Maternal Cannabis Use During Pregnancy Associated With Adverse Health Outcomes
December 12th 2023A recent study found that cannabis exposure over the course a pregnancy was associated with small-for-gestational-age birth, medically indicated preterm birth, stillbirth, or hypertensive disorders of pregnancy.
Pharmacist-Led Intervention Could Help Lower Rates of Inappropriate Aspirin Use
December 5th 2023Updated guidance from the United States Preventive Services Task Force advises against low-dose aspirin use as a primary prevention of atherosclerotic cardiovascular disease in certain populations who have bleeding risks.
Instagram Could Serve as Educational Platform for New FDA Drug Approvals
December 4th 2023An evaluative study on an open resource Instagram page that provides information on new medications to pharmacists was recently presented at the American Society of Health-System Pharmacists 2023 Midyear Clinical Meeting and Exhibition.